Sassicaia Capital Advisers LLC Moderna, Inc. Transaction History
Sassicaia Capital Advisers LLC
- $4.14 Billion
- Q4 2024
A detailed history of Sassicaia Capital Advisers LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sassicaia Capital Advisers LLC holds 14,500 shares of MRNA stock, worth $491,550. This represents 14.58% of its overall portfolio holdings.
Number of Shares
14,500Holding current value
$491,550% of portfolio
14.58%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
923Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.37 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.32 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$867 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$596 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$248 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...